comparemela.com

Latest Breaking News On - Launch diagnostics - Page 2 : comparemela.com

Avacta buys Belgium-based Coris Bioconcept for £7.4m

Avacta : Preliminary Results for the year ended 31 December 2022

A period of continued significant progress Avacta Group plc , a life sciences company developing innovative, targeted oncology drugs and powerful diagnostics, is pleased to. | April 25, 2023

Revenue rises, adjusted EBITDA loss improves for Avacta

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.